INTERNATIONAL GENOMICS CONSORTIUM

Welcome to the Brand page for “INTERNATIONAL GENOMICS CONSORTIUM”, which is offered here for Distributing clinical specimens, such as blood and tissue samples, to research entities for correlative studies;medical research support services, recruitment of patients and subjects for various studies;genomics consortium;research and scientific analysis, molecular and genomic sequencing and analysis comprising genomic research, bioinformatics, and diagnostic technologies to analyze complex genetic diseases; collection, processing and storage of blood and tissue samples and associated genomic data and clinical outcome information, and utilizing standardized protocols linked to a centralized molecular profiling laboratory to perform such analysis. establishing and augmenting national and international standards for consent, tissue collection, clinical annotation, molecular analysis and representation of data; providing online medical and research information relating to biological samples obtained under standardized conditions, along with associated gene expression data and long-term patient clinical outcome data to accelerate the discovery of targets for therapy, prognosis and diagnosis; providing a research platform to allow users to facilitate transitioning of genomic discoveries from the bench to a patient's bedside to improve patient care; pharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials; medical research, collecting and analyzing clinical samples, analyzing clinical data, and dna sequencing all in the fields of genomics, biomedicine, biosciences, and bioinformatics; computer software development services in the fields of genomics, biomedicine, biosciences, and bioinformatics;.

Its status is currently believed to be active. Its class is unavailable. “INTERNATIONAL GENOMICS CONSORTIUM” is believed to be currently owned by “The International Genomics Consortium”.

Owner:
THE INTERNATIONAL GENOMICS CONSORTIUM
Owner Details
Description:
Distributing clinical specimens, such as blood and tissue samples, to research entities for correlative studies;medical research support services, recruitment of patients and subjects for various studies;GENOMICS CONSORTIUM;Research and scientific analysis, molecular and genomic sequencing and analysis comprising genomic research, bioinformatics, and diagnostic technologies to analyze complex genetic diseases; collection, processing and storage of blood and tissue samples and associated genomic data and clinical outcome information, and utilizing standardized protocols linked to a centralized molecular profiling laboratory to perform such analysis. Establishing and augmenting national and international standards for consent, tissue collection, clinical annotation, molecular analysis and representation of data; providing online medical and research information relating to biological samples obtained under standardized conditions, along with associated gene expression data and long-term patient clinical outcome data to accelerate the discovery of targets for therapy, prognosis and diagnosis; providing a research platform to allow users to facilitate transitioning of genomic discoveries from the bench to a patient's bedside to improve patient care; pharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials; medical research, collecting and analyzing clinical samples, analyzing clinical data, and DNA sequencing all in the fields of genomics, biomedicine, biosciences, and bioinformatics; computer software development services in the fields of genomics, biomedicine, biosciences, and bioinformatics;
Categories: DISTRIBUTING CLINICAL SPECIMENS